GRI Bio, Inc. (GRI) vs HCW Biologics Inc. (HCWB)

GRI Bio, Inc. and HCW Biologics Inc. are both Biotechnology companies. GRI Bio, Inc. and HCW Biologics Inc. are of similar size ($4.6M and $4.2M). HCW Biologics Inc. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. GRI Bio, Inc. has the higher net margin (0.00% vs −329.4%) and the higher return on invested capital (0.00% vs −36.2%). Across the 14 metrics below, GRI Bio, Inc. leads on 10 and HCW Biologics Inc. on 4.

Valuation

Metric GRI HCWB Biotechnology median
P/E 0.03 n/m 7.88
P/S n/m 0.38 11.47
P/B 0.36 0.35 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.74 n/m 0.74
EV/Sales n/m 1.30 10.73
Earnings yield 3,640.53% (1,429.91%) (28.84%)
Free cash flow yield (281.76%) (483.74%) (23.03%)

Profitability

Metric GRI HCWB Biotechnology median
Gross margin 0.00% 95.91% 65.16%
Operating margin 0.00% (114.02%) 0.00%
Net margin 0.00% (329.38%) 0.00%
Free cash flow margin 0.00% (180.57%) 0.00%
Return on equity (142.02%) (600.32%) (57.72%)
Return on assets (113.27%) (79.52%) (49.22%)
Return on invested capital 0.00% (36.15%) 0.00%

Growth

Metric GRI HCWB Biotechnology median
Revenue growth (TTM) — 706.96% 5.64%
EPS growth (last fiscal year) 92.12% 65.49% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GRI HCWB Biotechnology median
Debt to equity 0.00 0.88 0.00
Current ratio 10.30 0.06 4.73
Net debt to EBITDA 0.69 (0.40) 0.96

Dividend

Metric GRI HCWB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GRI HCWB Biotechnology median
Market cap 4.57m 4.18m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack